Skip to main content
. 2018 Feb 28;10(2):278–289. doi: 10.18632/aging.101389

Table 1. Characteristics of donors.

Young Middle-aged Old Subset*
(N=10) (N=80) (N=10) (N=52)
Female, no.(%) 7 (70.0) 40 (50.0) 6 (60.0) 25 (48.1)
Age, years 22.8 (1.5) 63.2 (7.3) 90.2 (0.5) 64.2 (6.9)
Member of long-lived family n/a 40 (50.0) n/a 26 (50.0)
Body mass index, kg/m2 22.2 (1.8)a 26.2 (4.1)b 25.4 (3.8) 25.9 (4.3)
Co-morbidities
Cerebrovascular accident 0/10 (0.0) 3/76 (3.9) 2/10 (20.0) 3/51 (5.9)
Chronic obstructive pulmonary disease 0/10 (0.0) 3/75 (4.0) 1/10 (10.0) 1/51 (2.0)
Diabetes mellitus 0/10 (0.0) 7/74 (9.5) 2/10 (20.0) 4/51 (7.8)
Hypertension 0/10 (0.0) 17/76 (22.4) 5/10 (50.0) 15/52 (28.8)
Malignancies 0/10 (0.0) 3/72 (4.2) 1/10 (10.0) 1/50 (2.0)
Myocardial infarction 0/10 (0.0) 0/75 (0.0) 3/10 (30.0) 1/52 (1.9)
Rheumatoid arthritis 0/10 (0.0) 0/76 (0.0) 3/10 (30.0) 0/52 (0.0)
Smoking, current 0/10 (0.0) 10/76 (13.2) 1/10 (10.0) 3/48 (6.3)

SD: standard deviation. a: N=8, b: N=77. N/a: not applicable. Data are depicted as either mean (SD) or number (%). Diseases and intoxications are given as no./total known (%). * This subset was used for the correlation between in vitro senescence markers versus in situ p16INK4a positive human fibroblasts (3B).